These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 19053282)

  • 1. Structural studies of human histone deacetylase 8 and its site-specific variants complexed with substrate and inhibitors.
    Dowling DP; Gantt SL; Gattis SG; Fierke CA; Christianson DW
    Biochemistry; 2008 Dec; 47(51):13554-63. PubMed ID: 19053282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structures of metal-substituted human histone deacetylase 8 provide mechanistic inferences on biological function .
    Dowling DP; Gattis SG; Fierke CA; Christianson DW
    Biochemistry; 2010 Jun; 49(24):5048-56. PubMed ID: 20545365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. General Base-General Acid Catalysis in Human Histone Deacetylase 8.
    Gantt SM; Decroos C; Lee MS; Gullett LE; Bowman CM; Christianson DW; Fierke CA
    Biochemistry; 2016 Feb; 55(5):820-32. PubMed ID: 26806311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor.
    Vannini A; Volpari C; Filocamo G; Casavola EC; Brunetti M; Renzoni D; Chakravarty P; Paolini C; De Francesco R; Gallinari P; Steinkühler C; Di Marco S
    Proc Natl Acad Sci U S A; 2004 Oct; 101(42):15064-9. PubMed ID: 15477595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases.
    Somoza JR; Skene RJ; Katz BA; Mol C; Ho JD; Jennings AJ; Luong C; Arvai A; Buggy JJ; Chi E; Tang J; Sang BC; Verner E; Wynands R; Leahy EM; Dougan DR; Snell G; Navre M; Knuth MW; Swanson RV; McRee DE; Tari LW
    Structure; 2004 Jul; 12(7):1325-34. PubMed ID: 15242608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of 'linkerless' hydroxamic acid inhibitor-HDAC8 complex confirms the formation of an isoform-specific subpocket.
    Tabackman AA; Frankson R; Marsan ES; Perry K; Cole KE
    J Struct Biol; 2016 Sep; 195(3):373-378. PubMed ID: 27374062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and Functional Influence of the Glycine-Rich Loop G
    Porter NJ; Christianson NH; Decroos C; Christianson DW
    Biochemistry; 2016 Dec; 55(48):6718-6729. PubMed ID: 27933794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-(4-Aroyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-alkylamides as a new class of synthetic histone deacetylase inhibitors. 1. Design, synthesis, biological evaluation, and binding mode studies performed through three different docking procedures.
    Mai A; Massa S; Ragno R; Cerbara I; Jesacher F; Loidl P; Brosch G
    J Med Chem; 2003 Feb; 46(4):512-24. PubMed ID: 12570373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substrate binding to histone deacetylases as shown by the crystal structure of the HDAC8-substrate complex.
    Vannini A; Volpari C; Gallinari P; Jones P; Mattu M; Carfí A; De Francesco R; Steinkühler C; Di Marco S
    EMBO Rep; 2007 Sep; 8(9):879-84. PubMed ID: 17721440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variable active site loop conformations accommodate the binding of macrocyclic largazole analogues to HDAC8.
    Decroos C; Clausen DJ; Haines BE; Wiest O; Williams RM; Christianson DW
    Biochemistry; 2015 Mar; 54(12):2126-35. PubMed ID: 25793284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and structural characterization of HDAC8 mutants associated with Cornelia de Lange syndrome spectrum disorders.
    Decroos C; Christianson NH; Gullett LE; Bowman CM; Christianson KE; Deardorff MA; Christianson DW
    Biochemistry; 2015 Oct; 54(42):6501-13. PubMed ID: 26463496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active Site Metal Identity Alters Histone Deacetylase 8 Substrate Selectivity: A Potential Novel Regulatory Mechanism.
    Castaneda CA; Lopez JE; Joseph CG; Scholle MD; Mrksich M; Fierke CA
    Biochemistry; 2017 Oct; 56(42):5663-5670. PubMed ID: 28937750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Histone Deacetylase 8 (HDAC8) Selective Inhibition Reveals Specific Active Site Structural and Functional Determinants.
    Marek M; Shaik TB; Heimburg T; Chakrabarti A; Lancelot J; Ramos-Morales E; Da Veiga C; Kalinin D; Melesina J; Robaa D; Schmidtkunz K; Suzuki T; Holl R; Ennifar E; Pierce RJ; Jung M; Sippl W; Romier C
    J Med Chem; 2018 Nov; 61(22):10000-10016. PubMed ID: 30347148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of Histone Deacetylase 8: Structural and Mechanistic Analysis of the Phosphomimetic S39E Mutant.
    Welker Leng KR; Castañeda CA; Decroos C; Islam B; Haider SM; Christianson DW; Fierke CA
    Biochemistry; 2019 Nov; 58(45):4480-4493. PubMed ID: 31633931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and evaluation of 'Linkerless' hydroxamic acids as selective HDAC8 inhibitors.
    Krennhrubec K; Marshall BL; Hedglin M; Verdin E; Ulrich SM
    Bioorg Med Chem Lett; 2007 May; 17(10):2874-8. PubMed ID: 17346959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel structural insights into class I and II histone deacetylases.
    Ficner R
    Curr Top Med Chem; 2009; 9(3):235-40. PubMed ID: 19355988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docking of hydroxamic acids into HDAC1 and HDAC8: a rationalization of activity trends and selectivities.
    Ortore G; Di Colo F; Martinelli A
    J Chem Inf Model; 2009 Dec; 49(12):2774-85. PubMed ID: 19947584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone Deacetylase 8: Characterization of Physiological Divalent Metal Catalysis.
    Nechay MR; Gallup NM; Morgenstern A; Smith QA; Eberhart ME; Alexandrova AN
    J Phys Chem B; 2016 Jul; 120(26):5884-95. PubMed ID: 26996235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substrate and inhibitor specificity of class 1 and class 2 histone deacetylases.
    Hildmann C; Wegener D; Riester D; Hempel R; Schober A; Merana J; Giurato L; Guccione S; Nielsen TK; Ficner R; Schwienhorst A
    J Biotechnol; 2006 Jun; 124(1):258-70. PubMed ID: 16567013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the potential binding sites of some known HDAC inhibitors on some HDAC8 conformers by docking studies.
    Sixto-López Y; Gómez-Vidal JA; Correa-Basurto J
    Appl Biochem Biotechnol; 2014 Aug; 173(7):1907-26. PubMed ID: 24888409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.